Role of PPAR-&ggr; Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|5|5|377-386

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.5, Iss.5, 2005-01, pp. : 377-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR&ggr; in Angiogenesis and Vascular Development

By  

Current Angiogenesis, Vol. 1, Iss. 3, 2012-09 ,pp. : 192-205

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic Heart and the Cardiovascular Surgeon

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 8, Iss. 2, 2008-01 ,pp. : 147-152

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Disease in Patients with Diabetic Nephropathy

By  

Current Molecular Medicine, Vol. 8, Iss. 6, 2008-09 ,pp. : 533-543

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Diabetic Foot Ulcers

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 7, Iss. 1, 2007-02 ,pp. : 95-104

Bentham Science Publishers

Access to resources Recommend Favorite

The Surgical Treatment of Diabetic Obesity

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 7, Iss. 1, 2007-01 ,pp. : 19-29

Bentham Science Publishers

Access to resources Recommend Favorite